Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat for Purging HIV-1 From The Latent Reservoir (CLEAR)
NCT01680094Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Sep 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in human immunodeficiency virus infection (HIV), sponsored by Aarhus University. Started Sep 2012; status: completed.
02
Drugs
panobinostat
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01680094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01680094.